Literature DB >> 15322107

L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes.

Alexander Botzki1, Daniel J Rigden, Stephan Braun, Masatoshi Nukui, Sunnhild Salmen, Julia Hoechstetter, Günther Bernhardt, Stefan Dove, Mark J Jedrzejas, Armin Buschauer.   

Abstract

Hyaluronidases are enzymes that degrade hyaluronan, an important component of the extracellular matrix. The mammalian hyaluronidases are considered to be involved in many (patho)physiological processes like fertilization, tumor growth, and metastasis. Bacterial hyaluronidases, also termed hyaluronate lyases, contribute to the spreading of microorganisms in tissues. Such roles for hyaluronidases suggest that inhibitors could be useful pharmacological tools. Potent and selective inhibitors are not known to date, although L-ascorbic acid has been reported to be a weak inhibitor of Streptococcus pneumoniae hyaluronate lyase (SpnHL). The x-ray structure of SpnHL complexed with L-ascorbic acid has been elucidated suggesting that additional hydrophobic interactions might increase inhibitory activity. Here we show that L-ascorbic acid 6-hexadecanoate (Vcpal) is a potent inhibitor of both streptococcal and bovine testicular hyaluronidase (BTH). Vcpal showed strong inhibition of Streptococcus agalactiae hyaluronate lyase with an IC(50) of 4 microM and weaker inhibition of SpnHL and BTH with IC(50) values of 100 and 56 microM, respectively. To date, Vcpal has proved to be one of the most potent inhibitors of hyaluronidase. We also determined the x-ray structure of the SpnHL-Vcpal complex and confirmed the hypothesis that additional hydrophobic interactions with Phe-343, His-399, and Thr-400 in the active site led to increased inhibition. A homology structural model of BTH was also generated to suggest binding modes of Vcpal to this hyaluronidase. The long alkyl chain seemed to interact with an extended, hydrophobic channel formed by mostly conserved amino acids Ala-84, Leu-91, Tyr-93, Tyr-220, and Leu-344 in BTH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322107     DOI: 10.1074/jbc.M406146200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2.

Authors:  J A Sloane; C Batt; Y Ma; Z M Harris; B Trapp; T Vartanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

2.  Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling.

Authors:  Ling Zhu; Xiaoyu Liu; Daniel P Nemeth; Damon J DiSabato; Kristina G Witcher; Daniel B Mckim; Braedan Oliver; Xi Le; Gowthami Gorantla; Olimpia Berdysz; Jiaoni Li; Aishwarya D Ramani; Zhibiao Chen; Dongcheng Wu; Jonathan P Godbout; Ning Quan
Journal:  Brain Behav Immun       Date:  2019-06-19       Impact factor: 7.217

Review 3.  Hyaluronidases: their genomics, structures, and mechanisms of action.

Authors:  Robert Stern; Mark J Jedrzejas
Journal:  Chem Rev       Date:  2006-03       Impact factor: 60.622

4.  A new mass spectrometry based bioassay for the direct assessment of hyaluronidase activity and inhibition.

Authors:  Emily R Britton; Carolyn B Ibberson; Alexander R Horswill; Nadja B Cech
Journal:  J Microbiol Methods       Date:  2015-10-28       Impact factor: 2.363

5.  A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors.

Authors:  Taasin Srivastava; Parham Diba; Justin M Dean; Fatima Banine; Daniel Shaver; Matthew Hagen; Xi Gong; Weiping Su; Ben Emery; Daniel L Marks; Edward N Harris; Bruce Baggenstoss; Paul H Weigel; Larry S Sherman; Stephen A Back
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

6.  A polysaccharide lyase from Stenotrophomonas maltophilia with a unique, pH-regulated substrate specificity.

Authors:  Logan C MacDonald; Bryan W Berger
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

7.  Mycobacteria exploit host hyaluronan for efficient extracellular replication.

Authors:  Yukio Hirayama; Mamiko Yoshimura; Yuriko Ozeki; Isamu Sugawara; Tadashi Udagawa; Satoru Mizuno; Naoki Itano; Koji Kimata; Aki Tamaru; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

Review 8.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 9.  Hyalurondiase: both a tumor promoter and suppressor.

Authors:  Vinata B Lokeshwar; Marie G Selzer
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

10.  Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues.

Authors:  Ling Zhang; Alamelu G Bharadwaj; Andrew Casper; Joel Barkley; Joseph J Barycki; Melanie A Simpson
Journal:  J Biol Chem       Date:  2009-02-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.